Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin
Despite extensive treatment, glioblastoma inevitably recurs, leading to an overall survival of around 16 months. Understanding why and how tumours resist to radio/chemotherapies is crucial to overcome this unmet oncological challenge. Primary and acquired resistance to Temozolomide (TMZ), the standa...
Main Authors: | Saidu Sani, Nikita Pallaoro, Mélissa Messe, Chloé Bernhard, Nelly Etienne-Selloum, Horst Kessler, Luciana Marinelli, Natacha Entz-Werle, Sophie Foppolo, Sophie Martin, Damien Reita, Monique Dontenwill |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/2/369 |
Similar Items
-
The structure and function of integrins
by: Douglass, W
Published: (1997) -
Nascent Adhesion Clustering: Integrin-Integrin and Integrin-Substrate Interactions
by: Kuanpo Lin, et al.
Published: (2022-01-01) -
Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma
by: Nelly Etienne-Selloum, et al.
Published: (2021-08-01) -
Editorial: Integrin adhesion receptors in health and disease
by: Vassiliki Kostourou, et al.
Published: (2023-02-01) -
β1 integrins as therapeutic targets to disrupt hallmarks of cancer
by: Anne-Florence eBlandin, et al.
Published: (2015-11-01)